DD-Cas9 with filler sequence and Venus (EDCPV) Citations (7)

Originally described in: Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization.
Senturk S, Shirole NH, Nowak DG, Corbo V, Pal D, Vaughan A, Tuveson DA, Trotman LC, Kinney JB, Sordella R Nat Commun. 2017 Feb 22;8:14370. doi: 10.1038/ncomms14370. PubMed Journal

---

Articles Citing DD-Cas9 with filler sequence and Venus (EDCPV)

Articles
Mutant p53 amplifies a dynamin-1/APPL1 endosome feedback loop that regulates recycling and migration. Lakoduk AM, Roudot P, Mettlen M, Grossman HM, Schmid SL, Chen PH. J Cell Biol. 2019 Jun 3;218(6):1928-1942. doi: 10.1083/jcb.201810183. Epub 2019 May 1. PubMed
Genetic determinants of cellular addiction to DNA polymerase theta. Feng W, Simpson DA, Carvajal-Garcia J, Price BA, Kumar RJ, Mose LE, Wood RD, Rashid N, Purvis JE, Parker JS, Ramsden DA, Gupta GP. Nat Commun. 2019 Sep 19;10(1):4286. doi: 10.1038/s41467-019-12234-1. PubMed
Enhancing CRISPR deletion via pharmacological delay of DNA-PKcs. Bosch-Guiteras N, Uroda T, Guillen-Ramirez HA, Riedo R, Gazdhar A, Esposito R, Pulido-Quetglas C, Zimmer Y, Medova M, Johnson R. Genome Res. 2021 Mar;31(3):461-471. doi: 10.1101/gr.265736.120. Epub 2021 Feb 11. PubMed
A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization. Safaric Tepes P, Sordella R. J Vis Exp. 2021 Sep 2;(175). doi: 10.3791/60685. PubMed
Targeting G-quadruplex for rescuing impaired chondrogenesis in WRN-deficient stem cells. Leung AO, Yiu TC, Liu L, Tam HY, Gu S, Tu J, Pei D, Cheung HH. Cell Biosci. 2022 Dec 31;12(1):212. doi: 10.1186/s13578-022-00939-8. PubMed
VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer. Lee YS, Klomp JE, Stalnecker CA, Goodwin CM, Gao Y, Droby GN, Vaziri C, Bryant KL, Der CJ, Cox AD. Genes Cancer. 2023 Mar 10;14:30-49. doi: 10.18632/genesandcancer.231. eCollection 2023. PubMed
Patient-derived response estimates from zero-passage organoids of luminal breast cancer. Przanowska RK, Labban N, Przanowski P, Hawes RB, Atkins KA, Showalter SL, Janes KA. bioRxiv [Preprint]. 2024 Mar 27:2024.03.24.586432. doi: 10.1101/2024.03.24.586432. PubMed

If you have published an article using this material, please email us at to have your article added to this page.